A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34bright and AC133dim/-CD34+ human cord blood cells

被引:41
|
作者
Goussetis, E [1 ]
Theodosaki, M
Paterakis, G
Peristeri, J
Petropoulos, D
Kitra, V
Papassarandis, C
Graphakos, S
机构
[1] St Sophia Childrens Hosp, Bone Marrow Transplantat Unit, Athens 11527, Greece
[2] G Genimmatas Gen Dist Hosp, Dept Immunol, Athens, Greece
[3] G Genimmatas Gen Dist Hosp, Natl Histocompatibil Ctr, Athens, Greece
来源
关键词
D O I
10.1089/152581600750062255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 5-transmembrane receptor AC133 is expressed on a subpopulation of human hematopoietic cells that includes the CD34(bright) cells. We evaluated the developmental potential of AC133(+)CD34(bright) and AC133(dim-)CD34(+) cells isolated from 5 cord blood (CB) samples by studying the in vitro proliferative and differentiative potential of each population in both progenitor and mature cell expansion cultures. Seven-day culture of AC133(+)CD34(bright) cells with a cytokine combination favoring primitive progenitor cells causes a significant increase in CD34(+), CFU-C and noncycling stent/progenitor cells HPP-Q (High Proliferative Potential-Quiescent), whereas culture of AC133(dim/-)CD34(+) cells shows a limited increase in committed progenitor cells only. HPP-Q cells were not found in freshly isolated AC133(dim/-)CD34(+) nor in expanded CD34(+) cells derived from AC133(dim/-)CD34(+) cells. No statistically significant difference was observed between the 1-week expanded AC133(+) and the initial AC133(+)CD34(bright) cells regarding their clonogenic efficiency (CE), while expanded CD34(+) cells derived from AC133(dim/-)CD34(+) cells exhibited a decreased CE. Subexpansion of the reselected AC133+ derived from AC133(+)CD34(bright) cells reveals a further increase of stent/progenitor cells and the 14-day expanded AC133+ cells reveal an unchanged CE. Subexpansion of reselected 7-day CD34(+) cells derived from AC133(dim/-)CD34(+) cells was not possible. Culture of AC133(+)CD34(bright) cells in cytokines that favor megakaryopoiesis or erythropoiesis resulted in a significant expansion of CD41(+) and CD71(+) cells, respectively; AC133(dim/-)CD34(+), in comparison, showed a limited potential to megakaryocytic differentiation and a decreased production of erythroid cells. Our data indicate that early high proliferating stem/progenitor cells and early committed progenitors are present in AC133(+)CD34(bright) cells, but not in AC133(dim/-)CD34(+) cells; the latter represent late committed progenitors with limited proliferative potential.
引用
收藏
页码:827 / 840
页数:14
相关论文
共 50 条
  • [21] Infused CD34+/CD90+ cell number is more effective than CD34+/AC133+cells to predict late hematopoietic reconstitution following autologous peripheral blood stem cell transplantation.
    Shimazaki, C
    Sumikuma, T
    Inaba, T
    Ochiai, N
    Okano, A
    Hatsuse, M
    Ashihara, E
    Nakagawa, M
    BLOOD, 2001, 98 (11) : 321B - 321B
  • [22] Low oxygen tension favored expansion and hematopoietic reconstitution of CD34+ CD38- cells expanded from human cord blood-derived CD34+ Cells
    Wang, Ziyan
    Du, Zheng
    Cai, Haibo
    Ye, Zhaoyang
    Fan, Jinli
    Tan, Wen-Song
    BIOTECHNOLOGY JOURNAL, 2016, 11 (07) : 945 - 953
  • [23] The relationship between CD133+CD34-cells and CD34+haematopoietic progenitor cells in cord blood
    Ko, Kap-Hyoun
    Klamer, Guy
    Trickett, Annette
    Youngson, Joanna
    BONE MARROW TRANSPLANTATION, 2018, 53 : 524 - 525
  • [24] Exosomes from AC133+/CD34+ stem cells mediate a paracrine effect in breast cancer cells
    Ben Rahoma, Ghada
    Tuli, Neha
    Maniyar, Rachana
    Chakraborty, Sanjukta
    Singh, Sarnath
    Mittelman, Abraham
    Gelibter, Jan
    Tiwari, Raj K.
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Cord blood derived CD34+ and AC133+ progenitor cells ex-vivo expanded in the presence of tetraethylenepentamine:: Reproducibility among cord blood units
    Grynspan, F
    Peled, T
    Rosenheimer-Goudsmid, N
    Hana, L
    Hasson, N
    Mandel, J
    Landau, E
    Glukhman, E
    Harel, A
    Yudin, D
    Adi, S
    Olesinski, E
    Daniely, Y
    Hasson, A
    Harati, D
    Nagler, A
    Fibach, E
    Shpall, E
    BLOOD, 2004, 104 (11) : 119A - 119A
  • [26] MicroRNAs as Markers for Neurally Committed CD133+/CD34+ Stem Cells Derived from Human Umbilical Cord Blood
    Maryam Hafizi
    Amir Atashi
    Behnaz Bakhshandeh
    Mahboubeh Kabiri
    Samad Nadri
    Reza Haji Hosseini
    Masoud Soleimani
    Biochemical Genetics, 2013, 51 : 175 - 188
  • [27] Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors
    Peichev, M
    Naiyer, AJ
    Pereira, D
    Zhu, ZP
    Lane, WJ
    Williams, M
    Oz, MC
    Hicklin, DJ
    Witte, L
    Moore, MAS
    Rafii, S
    BLOOD, 2000, 95 (03) : 952 - 958
  • [28] Strategies for the small scale enrichment of cord blood hematopoietic cd34+ cells
    Neu S.
    Niethammer D.
    Handgretinger R.
    Pediatric Research, 1998, 44 (3) : 428 - 428
  • [29] FUNCTIONAL ASSESSMENT OF HEMATOPOIETIC LECTIN EXPRESSION ON CD34+ CELLS
    PIPIYA, G
    LONG, MW
    BLOOD, 1994, 84 (10) : A575 - A575
  • [30] Acquisition of CD34 correlates with increased hematopoietic and self renewal activity of CD34-CD133+cord blood cells
    Götze, KS
    Schiemann, M
    Marz, S
    Peschel, C
    Oostendorp, RAJ
    BLOOD, 2004, 104 (11) : 122B - 123B